Impact renaming non-alcoholic fatty liver disease to metabolic associated fatty liver disease in prevalence, characteristics and risk factors

Figure 1 Flow chart of the study population inclusion process. MAFLD: Metabolic associated fatty liver disease; NAFLD: Non-alcoholic fatty liver disease.

Figure 2 Prevalence of metabolic associated fatty liver disease and non-alcoholic fatty liver disease. MAFLD: Metabolic associated fatty liver disease; NAFLD: Non-alcoholic fatty liver disease.

Figure 3 Participants with metabolic associated fatty liver disease, non-alcoholic fatty liver disease, and those excluded by the two definitions. MAFLD: Metabolic associated fatty liver disease; NAFLD: Non-alcoholic fatty liver disease.

Figure 4 Prevalence of metabolic associated fatty liver disease by gender and age group. MAFLD: Metabolic associated fatty liver disease.

Figure 5 Prevalence of non-alcoholic fatty liver disease by gender and age group. NAFLD: Non-alcoholic fatty liver disease.

Figure 6 Non-alcoholic fatty liver disease and metabolic associated fatty liver disease prevalence by body mass index zone. MAFLD: Metabolic associated fatty liver disease; NAFLD: Non-alcoholic fatty liver disease; BMI: Body mass index.